Results 51 to 60 of about 4,961,010 (265)

The Unrecognized Prevalence of Primary Aldosteronism

Annals of Internal Medicine, 2020
BACKGROUND Primary aldosteronism is a nonsuppressible renin-independent aldosterone production that causes hypertension and cardiovascular disease. OBJECTIVE To characterize the prevalence of nonsuppressible renin-independent aldosterone production, as
Jenifer M. Brown, M. Siddiqui, D. Calhoun, R. Carey, P. Hopkins, G. Williams, A. Vaidya   +6 more
semanticscholar   +1 more source

Genetics of Primary Aldosteronism

HYPERTENSION, 2022
Primary aldosteronism is considered the commonest cause of secondary hypertension. In affected individuals, aldosterone is produced in an at least partially autonomous fashion in adrenal lesions (adenomas, [micro]nodules or diffuse hyperplasia). Over the
U. Scholl
semanticscholar   +1 more source

Masked arterial hypertension in a 64-year-old man with primary aldosteronism

Blood Pressure, 2022
Purpose Primary aldosteronism is one of the most frequent causes of secondary arterial hypertension, and whether primary aldosteronism is associated with masked hypertension is unknown.
Joanna Kanarek-Kucner, Beata Graff, Vlasta Bari, Rufus Barraclough, Krzysztof Narkiewicz, Michał Hoffmann   +5 more
doaj   +1 more source

Primary aldosteronism in pregnancy

Reviews in Endocrine & Metabolic Disorders, 2022
Primary aldosteronism (PA) is the most common form of secondary hypertension. Although hypertensive disorders seem to affect around 5–10% of pregnancies worldwide, literature counts less than 80 cases of PA diagnosed during the peri-partum period.
V. Forestiero, E. Sconfienza, P. Mulatero, S. Monticone   +3 more
semanticscholar   +1 more source

High Efficiency and Problems of Chemiluminescence Assay-Detected Aldosterone-To-Renin Ratio in Practical Primary Aldosteronism Screening

International Journal of Hypertension, 2020
Primary aldosteronism is a main cause of secondary hypertension which can be effectively treated. The screening test for primary aldosteronism is benefit for minimizing damage to the patient.
Wenbin Lin, Yuzhe Li, Dubo Chen, Zhenrong Yao, Hongxu Xu, Yonghong Chen, Jiahao Xiao, Pinning Feng, Wenjia Gan   +8 more
doaj   +1 more source

Primary aldosteronism and pregnancy

Репродуктивная эндокринология, 2022
The article is devoted to a review of scientific publications that study primary aldosteronism (PA), as well as its features during pregnancy. PA is the most common cause of secondary hypertension. There are few data on PA during pregnancy.
V.I. Medved, M.Y. Kyrylchuk, A.Y. Husieva   +2 more
doaj   +1 more source

Screening for primary aldosteronism is underutilised in patients with chronic kidney disease

JN. Journal of Nephrology (Milano. 1992), 2022
Primary aldosteronism (PA) is the most common and potentially curable endocrine cause of secondary hypertension, and carries a worse prognosis than essential hypertension.
Karanjeet Chauhan, Eitan Schachna, Renata Libianto, J. Ryan, Holly L. Hutton, P. Fuller, S. Wilson, P. Kerr, Jun-Hua Yang   +8 more
semanticscholar   +1 more source

Primary aldosteronism [PDF]

Reviews in Endocrine and Metabolic Disorders, 2011
Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice.
Satoh, Fumitoshi, Morimoto, Ryo, Iwakura, Yoshitsugu, Ono, Yoshikiyo, Kudo, Masataka, Takase, Kei, Ito, Sadayoshi   +6 more
openaire   +3 more sources

Unusual presentation of primary aldosteronism with advanced target organ damage: A case report

Radiology Case Reports, 2019
Patients with primary aldosteronism have greater cardiovascular morbidity and mortality than patients with primary hypertension and a comparable cardiovascular risk profile.
Cristiano Fava, MD, PhD, Filippo Cattazzo, MD, Riccardo Bernasconi, MD, Simone Romano, MD, Pietro Minuz, MD   +4 more
doaj   +1 more source

Characteristics and Outcomes in Primary Aldosteronism Patients Harboring Glucocorticoid-Remediable Aldosteronism

Biomedicines, 2021
The clinical characteristics and surgical prognosis of glucocorticoid-remediable aldosteronism (GRA, also known as familial hyperaldosteronism type 1, FH-I) have not been widely studied.
Chung-Yi Cheng, Hung-Wei Liao, Kang-Yung Peng, Tso-Hsiao Chen, Yen-Hung Lin, Jeff S. Chueh, Vin-Cent Wu, on behalf of the TAIPAI Study Group   +7 more
doaj   +1 more source